SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000890465-14-000065
Filing Date
2014-03-07
Accepted
2014-03-07 16:30:21
Documents
1
Period of Report
2014-03-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 2288
  Complete submission text file 0000890465-14-000065.txt   3618
Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address 550 HILLS DRIVE BEDMINSTER NJ 07921 (908) 450-5300
NPS PHARMACEUTICALS INC (Issuer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1301 2ND AVE., SUITE 3200 SEATTLE WA 98101
Business Address
Cvijic Christine Mikail (Reporting) CIK: 0001543663 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-23272 | Film No.: 14677652